|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C40B 30/04 | (2006.01) |
| G01N 33/574 | (2013.01) | ||
| G01N 33/574 | (2006.01) | ||
| G01N 33/57492 | (2013.01) | ||
| G01N2333/70596 | (2013.01) | ||
| G01N2800/52 | (2013.01) | ||
| C40B 30/04 | (2013.01) | ||
| G01N2500/02 | (2013.01) |
| (11) | Number of the document | 3802922 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19740098.9 |
| Date of filing the European patent application | 2019-06-10 | |
| (97) | Date of publication of the European application | 2021-04-14 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/036252 |
| Date | 2019-06-10 |
| (87) | Number | WO 2019/241098 |
| Date | 2019-12-19 |
| (30) | Number | Date | Country code |
| 201862683256 P | 2018-06-11 | US |
| (72) |
BLAIR, David A. , US
CHEN, Lieping , US
WANG, Jun , US
ZHENG, Timothy , US
|
| (73) |
Yale University ,
2 Whitney Avenue, New Haven, CT 06510,
US
Boehringer Ingelheim International GmbH , Binger Strasse 173, 55216 Ingelheim am Rhein, DE |
| (54) | NOVEL IMMUNE CHECKPOINT INHIBITORS |
| NOVEL IMMUNE CHECKPOINT INHIBITORS |